Integrated Filing — IndAS



General information about company

Scrip Code 506401
NSE Symbol DEEPAKNTR
MSEI Symbol NOTLISTED
ISIN INE288B01029
Name of company DEEPAK NITRITE LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Date of board meeting when results were approved 13-Aug-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 25-Jul-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 13-Aug-2025   14:30:00
End date and time of board meeting 13-Aug-2025   16:40:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 18898800000
Other income 245600000
Total income 19144400000
2 Expenses
(a) Cost of materials consumed 13310900000
(b) Purchases of stock-in-trade 638700000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -342500000
(d) Employee benefit expense 1064500000
(e) Finance costs 81300000
(f) Depreciation, depletion and amortisation expense 512500000
(f) Other Expenses
1 Power & fuel expenses 1136600000 1136600000
2 Other expenses 1195000000 1195000000
Total other expenses 2331600000
Total expenses 17597000000
3 Total profit before exceptional items and tax 1547400000
4 Exceptional items 0
5 Total profit before tax 1547400000
6 Tax expense
7 Current tax 419100000
8 Deferred tax 5800000
9 Total tax expenses 424900000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0
11 Net Profit Loss for the period from continuing operations 1122500000
12 Profit (loss) from discontinued operations before tax 0
13 Tax expense of discontinued operations 0
14 Net profit (loss) from discontinued operation after tax 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0
16 Total profit (loss) for period 1122500000
17 Other comprehensive income net of taxes -6700000
18 Total Comprehensive Income for the period 1115800000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 1122000000
Total profit or loss, attributable to non-controlling interests 500000
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 1116600000
Total comprehensive income for the period attributable to owners of parent non-controlling interests -800000
21 Details of equity share capital
Paid-up equity share capital 272800000
Face value of equity share capital 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 8.23
Diluted earnings (loss) per share from continuing operations 8.23
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0
Diluted earnings (loss) per share from discontinued operations 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 8.23
Diluted earnings (loss) per share from continuing and discontinued operations 8.23
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2025
Date of end of reporting period 30-Jun-2025
Whether accounts are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Advanced Intermediates 6053300000 6053300000
2 Phenolics 13039600000 13039600000
Total Segment Revenue 19092900000
Less: Inter segment revenue 194100000 194100000
Revenue from operations 18898800000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Advanced Intermediates 354700000 354700000
2 Phenolics 1179000000 1179000000
Total Profit before tax 1533700000
i. Finance cost 81300000 81300000
ii. Other Unallocable Expenditure net off Unallocable income -95000000 -95000000
Profit before tax 1547400000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Advanced Intermediates 25020100000 25020100000
2 Phenolics 25137400000 25137400000
Total Segment Asset 50157500000 50157500000
Un-allocable Assets 29982600000 29982600000
Net Segment Asset 80140100000 80140100000
4 Segment Liabilities
Segment Liabilities
1 Advanced Intermediates 5502500000 5502500000
2 Phenolics 7487300000 7487300000
Total Segment Liabilities 12989800000 12989800000
Un-allocable Liabilities 11788300000 11788300000
Net Segment Liabilities 24778100000 24778100000
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurements of the defined benefit plans -6000000 -6000000
2 Equity Instruments through Other Comprehensive Income (FVOCI) 500000 500000
Total Amount of items that will not be reclassified to profit and loss -5500000
2 Income tax relating to items that will not be reclassified to profit or loss -1400000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 2600000
5 Total Other comprehensive income -6700000





Details of Impact of Audit Qualification

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Deloitte Haskins & Sells LLP Yes 31-Jul-2027